Inspiratory Effort at Different Expiratory Cycling and Airway Resistance During Pressure Support Ventilation (CYCLOPES)
NCT ID: NCT05952726
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2023-08-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to answer to the following questions:
* which is the optimal expiratory cycling threshold where PMI better correlates with the esophageal pressure swing?
* what is the optimal correlation between the occlusion pressure (Poc) estimated by an expiratory occlusion manoeuvre and P0.1 with PMI obtained at various degrees of expiratory cycling threshold?
* does airway resistance - evaluated by using esophageal pressure - correlate with the estimation of airway resistance on the pressure-time waveform by a high percentage of expiratory cycling mimicking the interrupter technique?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Mechanical Insufflation-exsufflation on Airway Mucus Clearance in the ICU
NCT03178565
Optimization of Ventilator Setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT01291303
Neural Pressure Support, Synchrony and Respiratory Muscle Unloading
NCT05670093
Two Cycling Off Modes in Pressure Support: Study of Respiratory Mechanics, Breathing Comfort and Asynchrony Patterns
NCT00910286
Monitoring of Breathing Effort Through Pressure Time Product Measurement Using Airway Occlusion Pressure
NCT06040138
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At this time, the following parameters will be recorded:
* Patient demographics (including age, gender, height, weight, predicted body weight)
* Date/time of informed consent
* Date and time of hospital and ICU admission
* Comorbidities
* Smoking history and status
* Admission diagnoses
* Date/time of onset of mechanical ventilation
* Determinants of Sequential Organ Failure Assessment (SOFA) score at ICU admission
* Ventilation parameters, level of sedation (RASS scale), sedative drugs and arterial blood gas analysis on the day before the switch to PSV and at the study enrolment
* Prior use of adjunctive therapies including neuromuscular blocking agents (NMBA) and prone position
* Components of the SOFA score at the enrolment. Esophageal pressure will be measured by using a specific nasogastic feeding tube with an air-filled balloon. Three levels of pressure support will be explored randomly: a clinical pressure support, and 4 cmH2O of PS above and below the clinical pressure support At each level of pressure support, four sets of data will be recorded by randomly varying the expiratory cycling threshold: 15%, 30%, 45% and 60 % of peak inspiratory flow. After switching from one level of expiratory cycling to the new one, a ten minutes interval will be required before the data collection, in order to allow the patient to adapt to the new ventilation setting.
For each degree of expiratory cycling, the following parameters will be recorded:
* Ventilation parameters: PEEP, PS, Inspiratory and expiratory trigger, Inspiratory rising time
* Ventilatory mechanics measurements (3 times each): RR, TV, Ppeak, Pplat, total PEEP, P0.1, occlusion pressure (Poc), end-inspiratory Pes and end-expiratory Pes after and inspiratory and expiratory occlusion maneuvers of 3 seconds, respectively
* Esophageal pressure swings evaluation - 20 breaths for each level of pressure support ventilation and each level of expiratory cycling at steady state considered at the end of the 10 minute step.
In addition, the following parameters will be reported:
* Maximal Inspiratory Pressure (MIP) and Pes during MIP (one single measurement)
* Level of sedation (RASS scale) and type of sedative drugs
* Arterial blood gas analysis
* Determinants of SOFA Score. Patients will be followed up until ICU and hospital discharge. Data regarding ICU and hospital mortality will be collected, as well as total duration of mechanical ventilation, total duration of CMV and PSV.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prolonged expiratory cycling
15% expiratory cycling during pressure support ventilation
Expiratory cycling change at different levels of pressure support ventilation
Four different levels of expiratory cycling will be randomly applied at 3 different degrees of pressure support.
Three end-inspiratory and three end-expiratory occlusion manoeuvres will be carried out at the end of 10 minute steps of ventilation during each set value expiratory cycling and pressure support level.
Total study time will be about 120 minutes. Levels of pressure support wil be clinical pressure support ± 4 cmH2O; expiratory cycling percentages applied for each pressure support step will be 15%, 30%, 45% and 60% of peak inspiratory flow.
Late expiratory cycling
30% expiratory cycling during pressure support ventilation
Expiratory cycling change at different levels of pressure support ventilation
Four different levels of expiratory cycling will be randomly applied at 3 different degrees of pressure support.
Three end-inspiratory and three end-expiratory occlusion manoeuvres will be carried out at the end of 10 minute steps of ventilation during each set value expiratory cycling and pressure support level.
Total study time will be about 120 minutes. Levels of pressure support wil be clinical pressure support ± 4 cmH2O; expiratory cycling percentages applied for each pressure support step will be 15%, 30%, 45% and 60% of peak inspiratory flow.
Medium expiratory cycling
45% expiratory cycling during pressure support ventilation
Expiratory cycling change at different levels of pressure support ventilation
Four different levels of expiratory cycling will be randomly applied at 3 different degrees of pressure support.
Three end-inspiratory and three end-expiratory occlusion manoeuvres will be carried out at the end of 10 minute steps of ventilation during each set value expiratory cycling and pressure support level.
Total study time will be about 120 minutes. Levels of pressure support wil be clinical pressure support ± 4 cmH2O; expiratory cycling percentages applied for each pressure support step will be 15%, 30%, 45% and 60% of peak inspiratory flow.
Early expiratory cycling
60% expiratory cycling during pressure support ventilation
Expiratory cycling change at different levels of pressure support ventilation
Four different levels of expiratory cycling will be randomly applied at 3 different degrees of pressure support.
Three end-inspiratory and three end-expiratory occlusion manoeuvres will be carried out at the end of 10 minute steps of ventilation during each set value expiratory cycling and pressure support level.
Total study time will be about 120 minutes. Levels of pressure support wil be clinical pressure support ± 4 cmH2O; expiratory cycling percentages applied for each pressure support step will be 15%, 30%, 45% and 60% of peak inspiratory flow.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Expiratory cycling change at different levels of pressure support ventilation
Four different levels of expiratory cycling will be randomly applied at 3 different degrees of pressure support.
Three end-inspiratory and three end-expiratory occlusion manoeuvres will be carried out at the end of 10 minute steps of ventilation during each set value expiratory cycling and pressure support level.
Total study time will be about 120 minutes. Levels of pressure support wil be clinical pressure support ± 4 cmH2O; expiratory cycling percentages applied for each pressure support step will be 15%, 30%, 45% and 60% of peak inspiratory flow.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of spontaneous breathing activity (ventilator triggering), since 6 hours and no longer than 72 hours after
* Weaning from mechanical ventilation
* Patient for full active management
* Subject ≥ 18 years
* Informed consent
Exclusion Criteria
* Pregnancy
* Active air leaks
* Chronic Obstructive Pulmonary Disease and/or asthma
* Moribund state
* Neurological conditions potentially impairing the ventilatory drive (e.g. meningitis, encephalitis) and neuromuscular diseases impairing neuromuscular conduction (e.g. Guillain-Barre syndrome)
* Extracorporeal membrane oxygenation (ECMO)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione IRCCS San Gerardo dei Tintori
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emanuele Rezoagli, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Milano-Bicocca, Monza, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Foti G, Cereda M, Banfi G, Pelosi P, Fumagalli R, Pesenti A. End-inspiratory airway occlusion: a method to assess the pressure developed by inspiratory muscles in patients with acute lung injury undergoing pressure support. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1210-6. doi: 10.1164/ajrccm.156.4.96-02031.
Bellani G, Grassi A, Sosio S, Gatti S, Kavanagh BP, Pesenti A, Foti G. Driving Pressure Is Associated with Outcome during Assisted Ventilation in Acute Respiratory Distress Syndrome. Anesthesiology. 2019 Sep;131(3):594-604. doi: 10.1097/ALN.0000000000002846.
Teggia-Droghi M, Grassi A, Rezoagli E, Pozzi M, Foti G, Patroniti N, Bellani G. Comparison of Two Approaches to Estimate Driving Pressure during Assisted Ventilation. Am J Respir Crit Care Med. 2020 Dec 1;202(11):1595-1598. doi: 10.1164/rccm.202004-1281LE. No abstract available.
Bertoni M, Telias I, Urner M, Long M, Del Sorbo L, Fan E, Sinderby C, Beck J, Liu L, Qiu H, Wong J, Slutsky AS, Ferguson ND, Brochard LJ, Goligher EC. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care. 2019 Nov 6;23(1):346. doi: 10.1186/s13054-019-2617-0.
Bianchi I, Grassi A, Pham T, Telias I, Teggia Droghi M, Vieira F, Jonkman A, Brochard L, Bellani G. Reliability of plateau pressure during patient-triggered assisted ventilation. Analysis of a multicentre database. J Crit Care. 2022 Apr;68:96-103. doi: 10.1016/j.jcrc.2021.12.002. Epub 2021 Dec 21.
Pesenti A, Pelosi P, Foti G, D'Andrea L, Rossi N. An interrupter technique for measuring respiratory mechanics and the pressure generated by respiratory muscles during partial ventilatory support. Chest. 1992 Sep;102(3):918-23. doi: 10.1378/chest.102.3.918.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CYCLOPES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.